The regulation of the development and function of dendritic cell subsets by GM-CSF: More than a hematopoietic growth factor

Molecular Immunology

Volumn 52, Issue 1, 2012, Pages 30-37

  Zhan, Yifan ^a,b   Xu, Yuekang ^c   Lew, Andrew M ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b Department of Medical Biology ^*  (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Antigen presentation; Dendritic cells; Flt3L; GM CSF; Inflammation

Indexed keywords

DNA VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; NEUTRALIZING ANTIBODY;

AUTOIMMUNITY; BRAIN MALARIA; CANCER IMMUNOTHERAPY; CD8 DENDRITIC CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL SUBPOPULATION; CHRONIC INFLAMMATION; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; INFECTION; LISTERIA; MALARIA; MIGRATORY DENDRITIC CELL; MONOCYTE DERIVED DENDRITIC CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; RESIDENT DENDRITIC CELL; REVIEW;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; AUTOIMMUNITY; CELL DIFFERENTIATION; DENDRITIC CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HUMANS; INFLAMMATION; LISTERIA MONOCYTOGENES; MICE; MICE, KNOCKOUT; NEOPLASMS; RECOMBINANT PROTEINS;

EID: 84860798836     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.04.009     Document Type: Review

References (87)

1. Alaniz R.C., Sandall S., Thomas E.K., Wilson C.B. Increased dendritic cell numbers impair protective immunity to intracellular bacteria despite augmenting antigen-specific CD8+ T lymphocyte responses. Journal of Immunology 2004, 172:3725-3735.
2. Asselin-Paturel C., Boonstra A., Dalod M., Durand I., Yessaad N., Dezutter-Dambuyant C., Vicari A., O'Garra A., Biron C., Briere F., Trinchieri G. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nature Immunology 2001, 2:1144-1150.
3. Auriemma C., Viscardi M., Tafuri S., Pavone L.M., Capuano F., Rinaldi L., Della Morte R., Iovane G., Staiano N. Integrin receptors play a role in the internalin B-dependent entry of Listeria monocytogenes into host cells. Cellular and Molecular Biology Letters 2010, 15:496-506.
4. Bachem A., Guttler S., Hartung E., Ebstein F., Schaefer M., Tannert A., Salama A., Movassaghi K., Opitz C., Mages H.W., Henn V., Kloetzel P.M., Gurka S., Kroczek R.A. Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells. Journal of Experimental Medicine 2010, 207:1273-1281.
5. Bedoui S., Prato S., Mintern J., Gebhardt T., Zhan Y., Lew A.M., Heath W.R., Villadangos J.A., Segura E. Characterization of an immediate splenic precursor of CD8+ dendritic cells capable of inducing antiviral T cell responses. Journal of Immunology 2009, 182:4200-4207.
6. Bedoui S., Whitney P.G., Waithman J., Eidsmo L., Wakim L., Caminschi I., Allan R.S., Wojtasiak M., Shortman K., Carbone F.R., Brooks A.G., Heath W.R. Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nature Immunology 2009, 10:488-495.
7. Bogunovic M., Ginhoux F., Helft J., Shang L., Hashimoto D., Greter M., Liu K., Jakubzick C., Ingersoll M.A., Leboeuf M., Stanley E.R., Nussenzweig M., Lira S.A., Randolph G.J., Merad M. Origin of the lamina propria dendritic cell network. Immunity 2009, 31:513-525.
8. Broudy V.C., Kaushansky K., Harlan J.M., Adamson J.W. Interleukin 1 stimulates human endothelial cells to produce granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor. Journal of Immunology 1987, 139:464-468.
9. Caminschi I., Proietto A.I., Ahmet F., Kitsoulis S., Shin Teh J., Lo J.C., Rizzitelli A., Wu L., Vremec D., van Dommelen S.L., Campbell I.K., Maraskovsky E., Braley H., Davey G.M., Mottram P., van de Velde N., Jensen K., Lew A.M., Wright M.D., Heath W.R., Shortman K., Lahoud M.H. The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood 2008, 112:3264-3273.
10. Campbell I.K., Bendele A., Smith D.A., Hamilton J.A. Granulocyte-macrophage colony stimulating factor exacerbates collagen induced arthritis in mice. Annals of the Rheumatic Diseases 1997, 56:364-368.
11. Campbell I.K., Rich M.J., Bischof R.J., Hamilton J.A. The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. Journal of Leukocyte Biology 2000, 68:144-150.
12. Campbell I.K., van Nieuwenhuijze A., Segura E., O'Donnell K., Coghill E., Hommel M., Gerondakis S., Villadangos J.A., Wicks I.P. Differentiation of inflammatory dendritic cells is mediated by NF-{kappa}B1-dependent GM-CSF production in CD4T cells. Journal of Immunology 2011, 186:5468-5477.
13. Caux C., Vanbervliet B., Massacrier C., Dezutter-Dambuyant C., de Saint-Vis B., Jacquet C., Yoneda K., Imamura S., Schmitt D., Banchereau J. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. Journal of Experimental Medicine 1996, 184:695-706.
14. Cheong C., Matos I., Choi J.H., Dandamudi D.B., Shrestha E., Longhi M.P., Jeffrey K.L., Anthony R.M., Kluger C., Nchinda G., Koh H., Rodriguez A., Idoyaga J., Pack M., Velinzon K., Park C.G., Steinman R.M. Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. Cell 2010, 143:416-429.
15. Codarri L., Gyulveszi G., Tosevski V., Hesske L., Fontana A., Magnenat L., Suter T., Becher B. RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nature Immunology 2011, 12:560-567.
16. Crozat K., Guiton R., Contreras V., Feuillet V., Dutertre C.A., Ventre E., Vu Manh T.P., Baranek T., Storset A.K., Marvel J., Boudinot P., Hosmalin A., Schwartz-Cornil I., Dalod M. The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells. Journal of Experimental Medicine 2010, 207:1283-1292.
17. Daro E., Pulendran B., Brasel K., Teepe M., Pettit D., Lynch D.H., Vremec D., Robb L., Shortman K., McKenna H.J., Maliszewski C.R., Maraskovsky E. Polyethylene glycol-modified GM-CSF expands CD11b(high)CD11c(high) but notCD11b(low)CD11c(high) murine dendritic cells in vivo: a comparative analysis with Flt3 ligand. Journal of Immunology 2000, 165:49-58.
18. den Haan J.M., Lehar S.M., Bevan M.J. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. Journal of Experimental Medicine 2000, 192:1685-1696.
19. Dranoff G., Jaffee E., Lazenby A., Golumbek P., Levitsky H., Brose K., Jackson V., Hamada H., Pardoll D., Mulligan R.C. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:3539-3543.
20. Dresch C., Ackermann M., Vogt B., de Andrade Pereira B., Shortman K., Fraefel C. Thymic but not splenic CD8 DCs can efficiently cross-prime T cells in the absence of licensing factors. European Journal of Immunology 2011, 41:2544-2555.
21. Dzionek A., Fuchs A., Schmidt P., Cremer S., Zysk M., Miltenyi S., Buck D.W., Schmitz J. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. Journal of Immunology 2000, 165:6037-6046.
22. Edelson B.T., Bradstreet T.R., Hildner K., Carrero J.A., Frederick K.E., Kc W., Belizaire R., Aoshi T., Schreiber R.D., Miller M.J., Murphy T.L., Unanue E.R., Murphy K.M. CD8alpha(+) dendritic cells are an obligate cellular entry point for productive infection by Listeria monocytogenes. Immunity 2011, 35:236-248.
23. Edelson B.T., Bradstreet T.R., Wumesh K.C., Hildner K., Herzog J.W., Sim J., Russell J.H., Murphy T.L., Unanue E.R., Murphy K.M. Batf3-dependent CD11b(low/-) peripheral dendritic cells are GM-CSF-independent and are not required for Th cell priming after subcutaneous immunization. PLoS One 2011, 6:e25660.
24. El-Behi M., Ciric B., Dai H., Yan Y., Cullimore M., Safavi F., Zhang G.X., Dittel B.N., Rostami A. The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nature Immunology 2011, 12:568-575.
25. Enzler T., Gillessen S., Dougan M., Allison J.P., Neuberg D., Oble D.A., Mihm M., Dranoff G. Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of beta cells. Blood 2007, 110:954-961.
26. Enzler T., Gillessen S., Manis J.P., Ferguson D., Fleming J., Alt F.W., Mihm M., Dranoff G. Deficiencies of GM-CSF and interferon gamma link inflammation and cancer. Journal of Experimental Medicine 2003, 197:1213-1219.
27. Esashi E., Wang Y.H., Perng O., Qin X.F., Liu Y.J., Watowich S.S. The signal transducer STAT5 inhibits plasmacytoid dendritic cell development by suppressing transcription factor IRF8. Immunity 2008, 28:509-520.
28. Gaudreau S., Guindi C., Menard M., Besin G., Dupuis G., Amrani A. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells. Journal of Immunology 2007, 179:3638-3647.
29. Ginhoux F., Liu K., Helft J., Bogunovic M., Greter M., Hashimoto D., Price J., Yin N., Bromberg J., Lira S.A., Stanley E.R., Nussenzweig M., Merad M. The origin and development of nonlymphoid tissue CD103+ DCs. Journal of Experimental Medicine 2009, 206:3115-3130.
30. Gonzalez-Juarrero M., Hattle J.M., Izzo A., Junqueira-Kipnis A.P., Shim T.S., Trapnell B.C., Cooper A.M., Orme I.M. Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection. Journal of Leukocyte Biology 2005, 77:914-922.
31. Grage-Griebenow E., Zawatzky R., Kahlert H., Brade L., Flad H., Ernst M. Identification of a novel dendritic cell-like subset of CD64(+)/CD16(+) blood monocytes. European Journal of Immunology 2001, 31:48-56.
32. Grau G.E., Kindler V., Piguet P.F., Lambert P.H., Vassalli P. Prevention of experimental cerebral malaria by anticytokine antibodies. Interleukin 3 and granulocyte macrophage colony-stimulating factor are intermediates in increased tumor necrosis factor production and macrophage accumulation. Journal of Experimental Medicine 1988, 168:1499-1504.
33. Hamilton J.A. Colony-stimulating factors in inflammation and autoimmunity. Nature Reviews Immunology 2008, 8:533-544.
34. Hochrein H., Shortman K., Vremec D., Scott B., Hertzog P., O'Keeffe M. Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets. Journal of Immunology 2001, 166:5448-5455.
35. Iyoda T., Shimoyama S., Liu K., Omatsu Y., Akiyama Y., Maeda Y., Takahara K., Steinman R.M., Inaba K. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. Journal of Experimental Medicine 2002, 195:1289-1302.
36. Jackson J.T., Hu Y., Liu R., Masson F., D'Amico A., Carotta S., Xin A., Camilleri M.J., Mount A.M., Kallies A., Wu L., Smyth G.K., Nutt S.L., Belz G.T. Id2 expression delineates differential checkpoints in the genetic program of CD8alpha(+) and CD103(+) dendritic cell lineages. EMBO Journal 2011, 30:2690-2704.
37. Jongbloed S.L., Kassianos A.J., McDonald K.J., Clark G.J., Ju X., Angel C.E., Chen C.J., Dunbar P.R., Wadley R.B., Jeet V., Vulink A.J., Hart D.N., Radford K.J. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. Journal of Experimental Medicine 2010, 207:1247-1260.
38. Kaplan D.H., Jenison M.C., Saeland S., Shlomchik W.D., Shlomchik M.J. Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 2005, 23:611-620.
39. King I.L., Kroenke M.A., Segal B.M. GM-CSF-dependent, CD103+ dermal dendritic cells play a critical role in Th effector cell differentiation after subcutaneous immunization. Journal of Experimental Medicine 2010, 207:953-961.
40. Kingston D., Schmid M.A., Onai N., Obata-Onai A., Baumjohann D., Manz M.G. The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis. Blood 2009, 114:835-843.
41. Kobie J.J., Wu R.S., Kurt R.A., Lou S., Adelman M.K., Whitesell L.J., Ramanathapuram L.V., Arteaga C.L., Akporiaye E.T. Transforming growth factor beta inhibits the antigen-presenting functions and antitumor activity of dendritic cell vaccines. Cancer Research 2003, 63:1860-1864.
42. Lawlor K.E., Wong P.K., Campbell I.K., van Rooijen N., Wicks I.P. Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factor. Arthritis and Rheumatism 2005, 52:3749-3754.
43. Le P.T., Lazorick S., Whichard L.P., Yang Y.C., Clark S.C., Haynes B.F., Singer K.H. Human thymic epithelial cells produce IL-6, granulocyte-monocyte-CSF, and leukemia inhibitory factor. Journal of Immunology 1990, 145:3310-3315.
44. Lenhoff S., Sallerfors B., Olofsson T. IL-10 as an autocrine regulator of CSF secretion by monocytes: disparate effects on GM-CSF and G-CSF secretion. Experimental Hematology 1998, 26:299-304.
45. Leon B., Lopez-Bravo M., Ardavin C. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 2007, 26:519-531.
46. Lewis K.L., Caton M.L., Bogunovic M., Greter M., Grajkowska L.T., Ng D., Klinakis A., Charo I.F., Jung S., Gommerman J.L., Ivanov I.I., Liu K., Merad M., Reizis B. Notch2 receptor signaling controls functional differentiation of dendritic cells in the spleen and intestine. Immunity 2011, 35:780-791.
47. MacDonald K.P., Munster D.J., Clark G.J., Dzionek A., Schmitz J., Hart D.N. Characterization of human blood dendritic cell subsets. Blood 2002, 100:4512-4520.
48. Mach N., Gillessen S., Wilson S.B., Sheehan C., Mihm M., Dranoff G. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand. Cancer Research 2000, 60:3239-3246.
49. Mengaud J., Ohayon H., Gounon P., Mege R.M., Cossart P. E-cadherin is the receptor for internalin, a surface protein required for entry of L. monocytogenes into epithelial cells. Cell 1996, 84:923-932.
50. Merad M., Ginhoux F., Collin M. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nature Reviews Immunology 2008, 8:935-947.
51. Metcalf D. The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors. Blood 1986, 67:257-267.
52. Miller G., Pillarisetty V.G., Shah A.B., Lahrs S., Xing Z., DeMatteo R.P. Endogenous granulocyte-macrophage colony-stimulating factor overexpression in vivo results in the long-term recruitment of a distinct dendritic cell population with enhanced immunostimulatory function. Journal of Immunology 2002, 169:2875-2885.
53. Mittag D., Proietto A.I., Loudovaris T., Mannering S.I., Vremec D., Shortman K., Wu L., Harrison L.C. Human dendritic cell subsets from spleen and blood are similar in phenotype and function but modified by donor health status. Journal of Immunology 2011, 186:6207-6217.
54. Mollah Z.U., Pai S., Moore C., O'Sullivan B.J., Harrison M.J., Peng J., Phillips K., Prins J.B., Cardinal J., Thomas R. Abnormal NF-kappa B function characterizes human type 1 diabetes dendritic cells and monocytes. Journal of Immunology 2008, 180:3166-3175.
55. Naik S.H., Sathe P., Park H.Y., Metcalf D., Proietto A.I., Dakic A., Carotta S., O'Keeffe M., Bahlo M., Papenfuss A., Kwak J.Y., Wu L., Shortman K. Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nature Immunology 2007, 8:1217-1226.
56. Nakano H., Yanagita M., Gunn M.D. CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. Journal of Experimental Medicine 2001, 194:1171-1178.
57. Nambiar J.K., Ryan A.A., Kong C.U., Britton W.J., Triccas J.A. Modulation of pulmonary DC function by vaccine-encoded GM-CSF enhances protective immunity against Mycobacterium tuberculosis infection. European Journal of Immunology 2010, 40:153-161.
58. Neuenhahn M., Kerksiek K.M., Nauerth M., Suhre M.H., Schiemann M., Gebhardt F.E., Stemberger C., Panthel K., Schroder S., Chakraborty T., Jung S., Hochrein H., Russmann H., Brocker T., Busch D.H. CD8alpha+ dendritic cells are required for efficient entry of Listeria monocytogenes into the spleen. Immunity 2006, 25:619-630.
59. O'Keeffe M., Brodnicki T.C., Fancke B., Vremec D., Morahan G., Maraskovsky E., Steptoe R., Harrison L.C., Shortman K. Fms-like tyrosine kinase 3 ligand administration overcomes a genetically determined dendritic cell deficiency in NOD mice and protects against diabetes development. International Immunology 2005, 17:307-314.
60. Pooley J.L., Heath W.R., Shortman K. Cutting edge: intravenous soluble antigen is presented to CD4T cells by CD8- dendritic cells, but cross-presented to CD8T cells by CD8+ dendritic cells. Journal of Immunology 2001, 166:5327-5330.
61. Poulin L.F., Henri S., de Bovis B., Devilard E., Kissenpfennig A., Malissen B. The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells. Journal of Experimental Medicine 2007, 204:3119-3131.
62. Prasad S.J., Goodnow C.C. Cell-intrinsic effects of non-MHC NOD genes on dendritic cell generation in vivo. International Immunology 2002, 14:677-684.
63. Proietto A.I., O'Keeffe M., Gartlan K., Wright M.D., Shortman K., Wu L., Lahoud M.H. Differential production of inflammatory chemokines by murine dendritic cell subsets. Immunobiology 2004, 209:163-172.
64. Qiu C.H., Miyake Y., Kaise H., Kitamura H., Ohara O., Tanaka M. Novel subset of CD8{alpha}+ dendritic cells localized in the marginal zone is responsible for tolerance to cell-associated antigens. Journal of Immunology 2009, 182:4127-4136.
65. Riopel J., Tam M., Mohan K., Marino M.W., Stevenson M.M. Granulocyte-macrophage colony-stimulating factor-deficient mice have impaired resistance to blood-stage malaria. Infection and Immunity 2001, 69:129-136.
66. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. Journal of Experimental Medicine 1994, 179:1109-1118.
67. Sathe P., Pooley J., Vremec D., Mintern J., Jin J.O., Wu L., Kwak J.Y., Villadangos J.A., Shortman K. The acquisition of antigen cross-presentation function by newly formed dendritic cells. Journal of Immunology 2011, 186:5184-5192.
68. Serafini P., Carbley R., Noonan K.A., Tan G., Bronte V., Borrello I. High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells. Cancer Research 2004, 64:6337-6343.
69. Serbina N.V., Salazar-Mather T.P., Biron C.A., Kuziel W.A., Pamer E.G. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 2003, 19:59-70.
70. Shklovskaya E., O'Sullivan B.J., Ng L.G., Roediger B., Thomas R., Weninger W., Fazekas de St Groth B. Langerhans cells are precommitted to immune tolerance induction. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:18049-18054.
71. Shortman K., Liu Y.J. Mouse and human dendritic cell subtypes. Nature Reviews Immunology 2002, 2:151-161.
72. Steptoe R.J., Ritchie J.M., Harrison L.C. Increased generation of dendritic cells from myeloid progenitors in autoimmune-prone nonobese diabetic mice. Journal of Immunology 2002, 168:5032-5041.
73. Szeliga J., Daniel D.S., Yang C.H., Sever-Chroneos Z., Jagannath C., Chroneos Z.C. Granulocyte-macrophage colony stimulating factor-mediated innate responses in tuberculosis. Tuberculosis (Edinb) 2008, 88:7-20.
74. van de Laar L., Coffer P.J., Woltman A.M. Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy. Blood 2012.
75. Varol C., Vallon-Eberhard A., Elinav E., Aychek T., Shapira Y., Luche H., Fehling H.J., Hardt W.D., Shakhar G., Jung S. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity 2009, 31:502-512.
76. Villadangos J.A., Schnorrer P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nature Reviews Immunology 2007, 7:543-555.
77. Villadangos J.A., Shortman K. Found in translation: the human equivalent of mouse CD8+ dendritic cells. Journal of Experimental Medicine 2010, 207:1131-1134.
78. Villadangos J.A., Young L. Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 2008, 29:352-361.
79. Vremec D., Lieschke G.J., Dunn A.R., Robb L., Metcalf D., Shortman K. The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs. European Journal of Immunology 1997, 27:40-44.
80. Vremec D., Shortman K. Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. Journal of Immunology 1997, 159:565-573.
81. Wakim L.M., Waithman J., van Rooijen N., Heath W.R., Carbone F.R. Dendritic cell-induced memory T cell activation in nonlymphoid tissues. Science 2008, 319:198-202.
82. Weiss W.R., Ishii K.J., Hedstrom R.C., Sedegah M., Ichino M., Barnhart K., Klinman D.M., Hoffman S.L. A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine. Journal of Immunology 1998, 161:2325-2332.
83. Wodnar-Filipowicz A., Heusser C.H., Moroni C. Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation. Nature 1989, 339:150-152.
84. Xu Y., Zhan Y., Lew A.M., Naik S.H., Kershaw M.H. Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking. Journal of Immunology 2007, 179:7577-7584.
85. Zhan Y., Carrington E.M., van Nieuwenhuijze A., Bedoui S., Seah S., Xu Y., Wang N., Mintern J.D., Villadangos J.A., Wicks I.P., Lew A.M. GM-CSF increases cross-presentation and CD103 expression by mouse CD8 spleen dendritic cells. European Journal of Immunology 2011, 41:2585-2595.
86. Zhan Y., Cheers C. Haemopoiesis in mice genetically lacking granulocyte-macrophage colony stimulating factor during chronic infection with Mycobacterium avium. Immunology and Cell Biology 2000, 78:118-123.
87. Zhan Y., Xu Y., Seah S., Brady J.L., Carrington E.M., Cheers C., Croker B.A., Wu L., Villadangos J.A., Lew A.M. Resident and monocyte-derived dendritic cells become dominant IL-12 producers under different conditions and signaling pathways. Journal of Immunology 2010, 185:2125-2133.